Squeeze Report — November 18, 2026
No high-conviction squeezes on today's board, but the real story is the cluster of stale short-interest prints colliding with heavy dilution events — CVI's Marathon financing, AAOI's $550M ATM, and SUPN's Indivior close all expand float right as bears ease off.
Today's top short-squeeze candidates
- #1ACHCAcadia Healthcare Company, Inc78
22% of float sold short · 11.2 days to cover · +21% over 20 days
SI 22%DTC 11.2$37.94+21% 20dHealthcare - #2CVICVR ENERGY, INC.77
The Marathon deal's common stock offering is a live dilution overhang that could expand the float shorts are already exiting.
SI 19%DTC 7.5$38.01-39% 20dEnergy - #3ABSIAbsci Corporation Common Stock75
December's ABS-201 POC readout is a binary event priced into 196% December IV, with shorts already reducing.
SI 24%DTC 9.1$7.58-16% 20dHealthcare - #4AADXApplied Aerospace & Defense, I72
The 28.5% short float is hollow: a 74% controlling holder and 1B authorized shares cap any squeeze.
SI 29%DTC 4.0$6.85-38% 20dIndustrials - #5AAPADVANCE AUTO PARTS INC71
Shorts covered 11.3% and Stifel's Hold at $47 with DIY traffic down 5% shows the bear case is still loaded.
SI 16%DTC 6.4$44.07-0% 20dConsumer Cyclical - #6AAONAAON, Inc. Common Stock62
Data-center cooling backlog is real, but the FINRA print is 19 days stale and short volume is fading.
SI 9%DTC 6.2$78.71+6% 20dIndustrials - #7ABCLAbCellera Biologics Inc. Commo60
A 209M-share float plus August's dilutive offering smothers any squeeze despite the 8.49 days-to-cover optics.
SI 14%DTC 8.5$11.03-6% 20dHealthcare - #8PDPagerDuty, Inc.57
Net retention fell to 98% and a 15% workforce cut says this is a fundamental short, not a squeeze setup.
SI 11%DTC 4.9$15.34-9% 20dTechnology - #9ACIAlbertsons Companies, Inc.56
A 16.7% short float looks juicy, but shorts covered 6.7% last print and the opioid verdict adds liability risk.
SI 17%DTC 5.5$12.95-4% 20dConsumer Defensive - #10AAOIApplied Optoelectronics, Inc.52
The new $550M ATM on top of a prior $600M program means supply, not shorts, is the problem.
SI 21%DTC 1.6$45.22-41% 20dTechnology - #11NBIXNeurocrine Biosciences, Inc. C51
The 16.8% rally came with shorts reducing 8.5%, not trapped — and February earnings are too far out.
SI 6%DTC 5.4$165.92+17% 20dHealthcare - #12ADCAgree Realty Corporation50
A 13% short-interest jump is undercut by cheap borrow and a $1.75B ATM that keeps replenishing the float.
SI 7%DTC 5.3$68.95+3% 20dReal Estate - #13ACADACADIA Pharmaceuticals Inc. Co49
The RADIANT miss already repriced the bear case, and a falling 4.9% short float leaves no forced-covering pressure.
SI 5%DTC 5.9$18.32-10% 20dHealthcare - #14ACMAecom46
The 36% 20-day run already flushed weak hands, and the Nov 16 earnings catalyst has fully passed.
SI 5%DTC 5.8$80.53+37% 20dIndustrials - #15SUPNSupernus Pharmaceuticals, Inc.37
The all-stock Indivior close left Supernus holders with just 43.5% of the combined company — dilution kills the squeeze case.
SI 4%DTC 3.4$29.04-16% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →